Caramel: Dual-targeting (CD123/CD33) CAR-T cell as a bridge to allogeneic transplantation for Relapsed/Refractory Acute Myeloid Leukemia. preclinical Results.
Por:
Zugasti, I, Mulens-Arias, V, Espinosa-Aroca, L, Vinyoles, M, Martinez-Moreno, A, Roca-Ho, H, Rodriguez-Cortez, V, Engel, P, Albiol, N, Martinez-Cibrian, N, Oliver-Caldes, A, Ortiz-Maldonado, V, Cortés-Bullich, A, Castaño-Díez, S, Cardus, A, Jimenez-Vicente, C, Guijarro, F, Martinez-Roca, A, Rodriguez-Sevilla, JJ, Díaz-Beyá, M, Gonzalez, JD, Urbano-Ispizua, A, Esteve, J, Menéndez, P and Velasco-Hernandez, T
Publicada:
1 dic 2025
Ahead of Print:
1 dic 2025
Resumen:
Filiaciones:
Zugasti, I:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
:
Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain
:
Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain
:
Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain
:
Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain
:
Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain
Rodriguez-Cortez, V:
Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain
Engel, P:
Univ Barcelona, Dept Biomed Sci, Immunol Unit, Barcelona 08036, Spain
Albiol, N:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
Martinez-Cibrian, N:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
Oliver-Caldes, A:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
Ortiz-Maldonado, V:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
Cortés-Bullich, A:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
Castaño-Díez, S:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
Cardus, A:
August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
Jimenez-Vicente, C:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
Guijarro, F:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain
Martinez-Roca, A:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
Rodriguez-Sevilla, JJ:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
Díaz-Beyá, M:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
Univ Barcelona, Dept Biomed Sci, Immunol Unit, Barcelona 08036, Spain
Gonzalez, JD:
August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
Urbano-Ispizua, A:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
Esteve, J:
Hosp Clin Barcelona, Hematol Dept, ICAMS, Barcelona, Spain
August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
:
Josep Carreras Leukaemia Res Inst, Sch Med, Stem Cell Biol Dev Leukemia & Immunotherapy Lab, Barcelona 08036, Spain
Velasco-Hernandez, T:
Univ Barcelona, Dept Biomed Sci, Immunol Unit, Barcelona 08036, Spain
|